I write in response to the article "Blood-thinning drug’s guidelines may be flawed" (Irish Examiner, July 23).

A German pharmaceutical firm has agreed to pay $650m (€478m) to settle the majority of lawsuits filed over its blood thinner Pradaxa, which has been linked to more than 500 patient deaths.